Exactech Launches Significant Update to Equinoxe® Shoulder Preoperative Planning App

Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, today announces the U.S. release of the Equinoxe® Shoulder Planning App v2.1, giving surgeons increased flexibility to plan shoulder component placement and select implants and sizes for the scapula and humerus based on a patient’s specific anatomy.

The shoulder preoperative planning software can be used with the ExactechGPS® navigation system in the operating room, connecting the preoperative plan with implant placement. Recent studies demonstrate GPS provides verified placement accuracy within 2mm and 2 degrees of the preoperative plan1,2, better fixation1-4 and improved clinical outcomes compared to non-navigated groups, including improved range of motion and reduced postoperative complications, revision rates and adverse events.5

The latest Equinoxe Planning App version features:

Humeral planning, with a range of Equinoxe humeral stem components and sizes, including the Stemless Shoulder and Preserve short stem
Views for stem anterior/posterior, medial/lateral and inclination positions
Humeral head offset and position adjustment in anatomic procedures
Humeral tray and liner planning for reverse procedures
Patient neutral abduction position refinement
Views of the total joint and use of combined motions to assess shoulder range of motion and impingement at specific locations
A redesigned, enhanced user interface
Easy access to Predict+™, the first machine learning-based clinical decision support tool for shoulder surgery

“The enhancements to the Equinoxe Planning App allow me to truly personalize each reconstruction in a patient-specific fashion,” said Moby Parsons, MD, a joint replacement surgeon at The Knee, Hip and Shoulder Center (Portsmouth, NH) and Equinoxe/GPS design team member. “The addition of humeral-sided planning provides a full suite of planning solutions that incorporates the comprehensive portfolio of implants that Equinoxe offers. The ability to assess range of motion and impingement as a function of implant configuration complements my ability to determine the optimal plan that can positively impact each patient’s outcome. When combined with the actionable insights provided by Predict+, which has also been added to the Planning App, I can now manage solutions for my patients that are driven by Active Intelligence®.”

“Since the launch of the original Equinoxe Planning App, surgeons have planned more than 50,000 shoulder cases and executed their plans in 30,000+ cases using GPS,” said Exactech Senior Vice President of Extremities Chris Roche. “The Planning App, combined with GPS, makes the system the first and only shoulder navigation technology that connects the preoperative plan with real-time intraoperative instrument guidance – and verifies implant placement. The new features added to the Planning App highlight Exactech’s drive to create new solutions that enhance our surgeons’ surgical experiences.”

International market clearance of the Planning App v2.1 is targeted for the fourth quarter. Download the Equinoxe Planning App at www.AISurgeon.com and explore all of Exactech’s Active Intelligence technologies at www.AIExactech.com.

1Greene A. et al. Navigated vs. non-navigated results of a CT based computer assisted shoulder arthroplasty system in 30 cadavers. Presented at ISTA 2018.*
2Nashikkar P. et al. Role of intraoperative navigation in the fixation of the glenoid component in reverse total shoulder arthroplasty: a clinical case-control study. J Shoulder Elbow Surg. 2019 Sept.;28(9):1685-1691.
3Nashikkar P. et al. Computer navigation re-creates planned glenoid placement and reduces correction variability in total shoulder arthroplasty: an in vivo case-control study. J Shoulder Elbow Surg. 2019 Dec;28(12):e398-e409.
4Roche C. et al. Impact of screw length and screw quantity on rTSA glenoid fixation for two different sizes of glenoid baseplates. JSES Open Access (JSESOA-D-19-00048R1).*
5Greene A. et al. Two-year clinical outcomes of total shoulder arthroplasty performed with a computer navigated surgery system. Presented at CAOS 2022.
*In vitro (bench) test results may not necessarily be indicative of clinical performance.

The Equinoxe Planning App is used exclusively with the Equinoxe Platform Shoulder System and its comprehensive glenoid and humeral solutions. ExactechGPS and the Equinoxe Planning App are manufactured by Blue Ortho, a subsidiary of Exactech, and distributed by Exactech.

SourceExactech

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version